Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
about
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseOral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.Recent advances in the pharmacogenomics of thiopurine methyltransferase.Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanineThiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.Implementation of TPMT testing.Pharmacogenomics of pediatric acute lymphoblastic leukemia.TPMT in the treatment of Crohn's disease with azathioprine.Severe Myelotoxicity Associated with Thiopurine S-Methyltransferase*3A/*3C Polymorphisms in a Patient with Pediatric Leukemia and the Effect of Steroid Therapy.Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.Notes from the SNP vs. haplotype front
P2860
Q24632749-6B08A1CF-D21D-4AF5-B45F-6E55537F91A9Q28068930-AB6CD421-32C2-4EFC-AC83-A8742D142D9CQ33388076-EBF102A4-A1B7-46E8-A4CA-B7BD77B7A783Q34574036-0B2CC179-A19F-495C-A3C6-EFCF3D50122BQ35036160-EC5877BF-66BC-4C08-B719-3E1F6822FB87Q36393968-5026343B-829A-40E3-81A1-9C668C6106BFQ36532537-98702013-C4A7-442D-83B1-FBCF5901E36FQ36988021-300EA8E6-2E2C-4C57-B985-B192A3254425Q37678056-C80A0592-717A-4A9E-A710-B654F8485401Q37739432-B8839492-C433-4630-A973-36E820DDBEA8Q41762842-C864F993-1873-4170-82EA-4C1E719B9A28Q42129264-245119F4-8623-46F9-8B5A-1CAE654C2F59Q44577440-D83C6C2C-32B0-45AE-AA07-8482A40A85E7Q50708004-79A53376-934D-416B-9234-03D0501DE11FQ57555808-633E0B1D-5E51-4DFB-B89B-08894367E074
P2860
Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@ast
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@en
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@nl
type
label
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@ast
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@en
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@nl
prefLabel
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@ast
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@en
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@nl
P2093
P1476
Severe 6-thioguanine-induced m ...... methyltransferase deficiency.
@en
P2093
Gilchrist GS
McBride KL
Smithson WA
Szumlanski CL
P304
P356
10.1097/00043426-200009000-00011
P577
2000-09-01T00:00:00Z